John Hoekman Impel Pharmaceuticals Inc (IMPL) insider trading activity

IMPL Quotes by TradingView

John Hoekman is Chief Scientific Officer of IMPEL PHARMACEUTICALS INC. Currently has a direct ownership of 128,221 shares of IMPL, which is worth approximately $2,564. The most recent transaction as insider was on Dec 22, 2021, when has been sold 20,000 shares (Common Stock) at a price of $1.64 per share, resulting in proceeds of $32,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K
0% 3M change
0% 12M change
Total Value Held $2,564

John Hoekman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 22 2021
BUY
Exercise of conversion of derivative security
$32,800 $1.64 p/Share
20,000 Added 13.49%
128,221 Common Stock
Apr 27 2021
SELL
Other acquisition or disposition
-
275 Reduced 0.25%
108,221 Common Stock
Apr 27 2021
BUY
Conversion of derivative security
-
4,523 Added 4.0%
108,496 Common Stock
JH

John Hoekman

Chief Scientific Officer
Seattle, WA

Track Institutional and Insider Activities on IMPL

Follow IMPEL PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMPL shares.

Notify only if

Insider Trading

Get notified when an Impel Pharmaceuticals Inc insider buys or sells IMPL shares.

Notify only if

News

Receive news related to IMPEL PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IMPL